Darbepoetin alfa for treating anemia in patients with low-risk myelodysplastic syndromes: Exploratory analysis of baseline predictors of response

J. Gabrilove,R Paquette,Roger M. Lyons,Chaudhry Mushtaq,Mikkael A. Sekeres,Hung Lam,Lyndah Dreiling

Darbepoetin alfa for treating anemia in patients with low-risk myelodysplastic syndromes: Exploratory analysis of baseline predictors of response

2006

J. Gabrilove
R Paquette
Roger M. Lyons
Chaudhry Mushtaq
Mikkael A. Sekeres
Hung Lam
Lyndah Dreiling

6579 Background: Patients (pts) with myelodysplastic syndromes (MDS) often develop anemia, resulting in fatigue and increased transfusions. The erythropoiesis-stimulating agents (ESAs) epoetin alfa...

Keywords:

Physical therapy
Darbepoetin alfa
Anemia
Myelodysplastic syndromes
Medicine
Epoetin alfa
in patient
exploratory analysis
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations